Ladha Karim S, Patorno Elisabetta, Huybrechts Krista F, Liu Jun, Rathmell James P, Bateman Brian T
From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts (K.S.L., E.P., K.F.H., J.L., B.T.B.); Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (K.S.L., B.T.B.); Department of Anesthesia, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada (K.S.L.); and Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (J.P.R).
Anesthesiology. 2016 Apr;124(4):837-45. doi: 10.1097/ALN.0000000000001034.
Practice guidelines for perioperative pain management recommend that multimodal analgesic therapy should be used for all postsurgical patients. However, the proportion of patients who actually receive this evidence-based approach is unknown. The objective of this study was to describe hospital-level patterns in the utilization of perioperative multimodal analgesia.
Data for the study were obtained from the Premier Research Database. Patients undergoing below-knee amputation, open lobectomy, total knee arthroplasty, and open colectomy between 2007 and 2014 were included in the analysis. Patients were considered to have multimodal therapy if they received one or more nonopioid analgesic therapies. Mixed-effects logistic regression models were used to estimate the hospital-specific frequency of multimodal therapy use while adjusting for the case mix of patients and hospital characteristics and accounting for random variation.
The cohort consisted of 799,449 patients who underwent a procedure at 1 of 315 hospitals. The mean probability of receiving multimodal therapy was 90.4%, with 95% of the hospitals having a predicted probability between 42.6 and 99.2%. A secondary analysis examined whether patients received two or more nonopioid analgesics, which gave an average predicted probability of 54.2%, with 95% of the hospitals having a predicted probability between 9.3 and 93.2%.
In this large nationwide sample of surgical admissions in the United States, the authors observed tremendous variation in the utilization of multimodal therapy not accounted for by patient or hospital characteristics. Efforts should be made to identify why there are variations in the use of multimodal analgesic therapy and to promote its adoption in appropriate patients.
围手术期疼痛管理的实践指南建议,所有术后患者均应采用多模式镇痛疗法。然而,实际接受这种循证方法的患者比例尚不清楚。本研究的目的是描述围手术期多模式镇痛的医院层面使用模式。
本研究的数据来自Premier研究数据库。纳入分析的患者为2007年至2014年间接受膝下截肢术、开放性肺叶切除术、全膝关节置换术和开放性结肠切除术的患者。如果患者接受了一种或多种非阿片类镇痛疗法,则被视为接受了多模式治疗。使用混合效应逻辑回归模型来估计医院层面多模式治疗的使用频率,同时调整患者的病例组合和医院特征,并考虑随机变异。
该队列包括799449名在315家医院之一接受手术的患者。接受多模式治疗的平均概率为90.4%,95%的医院预测概率在42.6%至99.2%之间。一项二次分析检查了患者是否接受了两种或更多种非阿片类镇痛药,得出的平均预测概率为54.2%,95%的医院预测概率在9.3%至93.2%之间。
在美国这个全国性的大型手术入院样本中,作者观察到多模式治疗的使用存在巨大差异,且这种差异无法用患者或医院特征来解释。应努力查明多模式镇痛疗法使用存在差异的原因,并促进其在合适患者中的应用。